MUSKOGEE, Okla. – A gunman killed five children, ages 1 to 9, and his 24-year-old brother in a mass shooting early Tuesday at a home in Muskogee, Oklahoma, where they
Nolan Clay and John Bacon
MUSKOGEE, Okla. – The suspect in a fatal shooting of a man and five children in their home was held Wednesday on multiple murder charges as investigators labored to determine what prompted the rampage.
Police said Jarron Deajon Pridgeon, 25, opened fire early Tuesday, killing his brother, Javarion Lee, 24, and the children, all under the age of 10. Pridgeon, 25, had been evaluated for mental illness after being charged with assault in 2019, court records show.
The children s mother, Brittany Anderson, suffered life-threatening injuries in the house and was airlifted to a Tulsa hospital, police said. She was in stable condition, police said.
5 children, man killed in Oklahoma shooting dailyindependent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyindependent.com Daily Mail and Mail on Sunday newspapers.
Staff reports | Muskogee Phoenix
Feb 2, 2021
The Muskogee Police Department has released the name of the suspect in a shooting spree early Tuesday morning that claimed the lives of six people, five of them children, and left a woman in critical condition.
Muskogee PD Public Information Officer Lynn Hamlin said Jarron Deajon Pridgeon, 25, was taken into custody following a brief foot pursuit. The suspect, who was wielding a gun at the time of his arrest, is not cooperating with law enforcement officials at this time, Hamlin said.
Online court records show that Pridgeon had one arrest in 2017, for larceny of an automobile. In February 2019, he was charged with assault and battery with a dangerous weapon, threatening to perform acts of violence, and misdemeanor malicious injury to private property. In June 2019, he was charged with obstruction, resisting an officer, and possession of a controlled dangerous substance. Those were filed as misdemeanors.
Altus Formulation Inc.: Cadila Pharmaceuticals and Altus Formulation Announce Successful Clinical Studies with TramaFlex Breakable Extended-Release Tablets
tm Modified Release Technology Platform:
New Safer to Use Value Added Tablets
AHMEDABAD, INDIA and LAVAL, QC / ACCESSWIRE / January 27, 2021 / Cadila Pharmaceuticals Limited (
Cadila ) and
Altus ) today announced the successful completion of human clinical studies with TramaFlex
TM breakable extended-release (ER) tablets, a novel value-added once-daily formulation of tramadol hydrochloride for the improved treatment of patients with moderate to moderately severe pain.
Developed by Altus using proprietary AmyloFlex
TM technology, human bio-equivalence studies conducted by Cadila demonstrated TramaFlex ER tablets are bio-equivalent to 24hr ER products available commercially in North America, Europe, and Asia. Unlike marketed brands that can rapidly release their entire contents if damaged, with potentially life-threatenin